Delivery mode
Self-paced online, Instructor-led online
The training must be completed by June 30, 2027.
Location
live online
Language
English
Health Technology Commercialization and Export Expertise
A practice-oriented program for health technology professionals looking to strengthen their expertise in international commercialization, market analysis, and the strategic planning of export operations.
Health technology markets are global, complex, and heavily regulated. Successful commercialization requires simultaneous understanding of reimbursement systems, market selection, and pricing, as well as the ability to adapt strategy to the product's stage of development and clinical evidence. This program offers a current and hands-on overview of how health technology companies can build a viable commercialization strategy and enter international markets in a controlled and effective way.
The program integrates international market analysis, pricing and sales channel strategies, export regulation, and financing options into a practical whole. Participants will gain the skills to identify the right target markets, build value-based pricing, and plan the progression of export operations with financing, regulation, and distribution channels all taken into account.
The course consists of 13 online lectures that are recorded for later viewing, keynote presentations, practical exercises, and project work. Studies can be completed flexibly alongside work. The course is free of charge for participants.
This program is in English only. Participants must live in Finland.
Explore our other health technology courses:
The training has been funded by the Service Centre for Continuous Learning and Employment (SECLE). The Service Centre promotes the competence development of working-age people and the availability of skilled labour. The operations of the Service Centre are overseen by the Ministry of Education and Culture and the Ministry of Economic Affairs and Employment.
Content and Schedule
The program consists of 13 lectures, which you can attend live online or watch as recordings afterwards. In addition to the lectures, the program includes keynote speeches, practical exercises, and a project assignment. The program is designed to be completed alongside work and is delivered entirely online.
Lecture topics and live online sessions
| September 7, 2026 | 17:00-19:30 | Why and what - industry characteristics & course introduction |
| September 9, 2026 | 17:00-19:30 | Fit for the market and consequent actions with customers |
| September 14, 2026 | 17:00-19:30 | Role of medical regulations & standards from the sales point of view |
| September 16, 2026 | 17:00-19:30 | On strategy within and beyond sales - IP, business, pricing/licensing |
| September 21, 2026 | 17:00-19:00 | AI & Data in health tech, clinical research |
| September 23, 2026 | 17:00-19:00 | References, Key opinion leaders and pricing models |
| September 28, 2026 | 17:00-19:00 | Planning and organizing international sales - distributors, agents, subsidiaries, recruitment |
| September 30, 2026 | 17:00-19:00 | "Bullshitting", keeping promises and human touch |
| October 5, 2026 | 17:00-19:00 | Reimbursement, health economics and public procurement |
| October 12, 2026 | 17:00-19:00 | Brand, marketing, organizational sales |
| October 14, 2026 | 17:00-19:00 | Go-to-market strategy, countries and distribution strategy |
| October 19, 2026 | 17:00-19:00 | Funding for or from customers, incentives, margins and costs |
| October 21, 2026 | 17:00-19:00 | Art of health tech sales within the EU, the US, emerging markets and beyond - what we have learned |
Content
Lectures and keynote speeches 
Practical exercises 
Project assignment
Certificate
Upon completing the program, you will receive a certificate demonstrating your up-to-date expertise.
For
The training is designed for professionals working in, or aiming to move into, sales and marketing roles in the health technology sector, with a relevant background in technology, business, medicine, or health sciences.
Applicants eligible for admission include individuals who belong to the above target groups, have a learning need related to the program content, and possess sufficient prerequisites for acquiring the competencies the training aims to develop.
Learning Outcomes
Upon completing the program, participants will be able to:
-
Understand the full scope of health technology commercialization and assess how a product's development stage, clinical evidence, and target market structures influence strategic market entry decisions.
-
Analyze the potential of international health technology markets, identify the requirements of different segments, and direct sales and marketing activities based on reimbursement systems and market-specific pathways.
-
Build value-based pricing and select the most effective commercialization and sales channel strategy for the product and market, considering distributors, agent models, and direct sales.
-
Understand the financial and regulatory prerequisites of international health technology export operations and apply this knowledge to the planning of a coherent export strategy.
Instructors
Kai Kronström
Kai Kronström is the co-founder and CEO of EpiHeart. EpiHeart is a pioneering medical device company creating foundation for surgical administration of advanced cell therapies. It's a university spin-off company leveraging over 10 years of dedicated research conducted on three continents.
Program Fee and Registration
Fee
The training is funded by the Centre for Continuous Learning and Employment and is free of charge.
Eligibility to participate must be approved by SECLE before the training starts. Study rights begin once the funder has approved eligibility, at which point the student receives an invitation to the learning platform.
Registration
The training must be completed in full by June 30, 2027.
This program has adopted Aalto EE's new Customer ID, and it is delivered on Aalto Learning Experience Alex e-learning environment. Before ordering, please visit aaltoee.fi/customerid.
Program start